Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.8 USD | -3.33% | -6.79% | +26.71% |
Financials (USD)
Sales 2024 * | 38.27M | Sales 2025 * | 31.72M | Capitalization | 1.01B |
---|---|---|---|---|---|
Net income 2024 * | -193M | Net income 2025 * | -237M | EV / Sales 2024 * | 18 x |
Net cash position 2024 * | 318M | Net cash position 2025 * | 254M | EV / Sales 2025 * | 23.7 x |
P/E ratio 2024 * |
-5.23
x | P/E ratio 2025 * |
-4.61
x | Employees | 284 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 11.38% |
Latest transcript on Bicycle Therapeutics plc
1 day | -0.17% | ||
1 week | -4.50% | ||
Current month | +0.55% | ||
1 month | +2.21% | ||
3 months | +36.85% | ||
6 months | +67.83% | ||
Current year | +30.42% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Lee
CEO | Chief Executive Officer | 55 | 15-08-31 |
Alethia Young
DFI | Director of Finance/CFO | 45 | 23-07-16 |
Alistair Milnes
COO | Chief Operating Officer | 50 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pierre Legault
CHM | Chairman | 63 | 19-03-17 |
Director/Board Member | 61 | 21-03-16 | |
Richard Kender
BRD | Director/Board Member | 68 | 19-07-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 22.91 | -2.84% | 101 229 |
24-05-09 | 23.58 | -0.17% | 102,388 |
24-05-08 | 23.62 | +2.34% | 227,971 |
24-05-07 | 23.08 | -0.94% | 258,359 |
24-05-06 | 23.3 | -5.21% | 424,084 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.42% | 1.01B | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.65% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- BCYC Stock